Skip to content

HealthCap’s 35th IPO as HealthCap VI company Wilson Therapeutics completes listing on Nasdaq OMX Stockholm

Wilson Therapeutics AB a rare disease focused biopharmaceutical company has successfully completed its Initial Public Offering on Nasdaq OMX Stockholm’s main market. Trading started today under the ticker WTX.

Source: Wilson Therapeutics